Virus load and incidence of olfactory, gustatory, respiratory, gastrointestinal disorders in COVID-19 patients: A retrospective cohort study
- PMID: 34358409
- PMCID: PMC8444685
- DOI: 10.1111/coa.13844
Virus load and incidence of olfactory, gustatory, respiratory, gastrointestinal disorders in COVID-19 patients: A retrospective cohort study
Abstract
Objectives: This study investigated the relationship between viral load and the incidence of olfactory and gustatory dysfunction (OD and GD), the incidence of respiratory and gastrointestinal symptoms and the recovery of OD and GD in COVID-19 patients.
Design: A retrospective cohort study.
Setting and participants: This study was conducted on 599 outpatients' cases in Golestan province between February and June 2020.
Main outcome measures: The incidence, severity (complete or partial) and recovery time of OD and GD and their associations with cycle threshold (CT) values of SARS-CoV-2 polymerase chain reaction were assessed.
Results: The mean age of patients was 38.27 ± 13.62 years. The incidence of general symptoms included myalgia 70.1%, headache 51.8%, fever 47.7% and dyspnoea 21.4%. 41.9% of patients had gastrointestinal symptoms, including abdominal pain 26.5%, diarrhoea 25.2%, nausea 20.5% and vomiting 12.9%. 12.2% of patients had comorbidity. The trimester recovery rates of OD and GD were 93.94% and 94.74% respectively. The mean recovery time of OD and GD was 14.56 ± 13.37 and 13.8 ± 3.77 days respectively. The mean CT value in all patients was 27.45 ± 4.55. There were significant associations between the mean of CT value with headache (p = 0.04), GD (p = 0.002) and OD (p = 0.001).
Conclusions: The finding of this study indicates a possible association between viral load with incidence of OD and GD in COVID-19 patient's cases and assures the recovery of OD/GD in these patients.
Keywords: COVID-19; gustatory disorders; olfaction disorders; taste disorders; viral load.
© 2021 John Wiley & Sons Ltd.
Conflict of interest statement
None declared.
Figures
Comment in
-
Physiological plausibility of lower viral load in patients with COVID-19 and olfactory/gustatory dysfunction.Clin Otolaryngol. 2022 Mar;47(2):397-398. doi: 10.1111/coa.13892. Epub 2021 Nov 29. Clin Otolaryngol. 2022. PMID: 34773392 Free PMC article. No abstract available.
Similar articles
-
COVID-19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction.Laryngoscope. 2020 Nov;130(11):2680-2685. doi: 10.1002/lary.29056. Epub 2020 Sep 8. Laryngoscope. 2020. PMID: 32794209 Free PMC article.
-
Prevalence and recovery time of olfactory and gustatory dysfunction in hospitalized patients with COVID‑19 in Wuhan, China.Int J Infect Dis. 2020 Nov;100:507-512. doi: 10.1016/j.ijid.2020.09.039. Epub 2020 Sep 17. Int J Infect Dis. 2020. PMID: 32950734 Free PMC article.
-
Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects.Otolaryngol Head Neck Surg. 2020 Dec;163(6):1144-1149. doi: 10.1177/0194599820939538. Epub 2020 Jun 30. Otolaryngol Head Neck Surg. 2020. PMID: 32600175 Free PMC article.
-
Long-term Consequences of COVID-19: Chemosensory Disorders.Curr Allergy Asthma Rep. 2023 Feb;23(2):111-119. doi: 10.1007/s11882-022-01062-x. Epub 2022 Dec 27. Curr Allergy Asthma Rep. 2023. PMID: 36574210 Free PMC article. Review.
-
Olfactory and gustatory dysfunctions in COVID-19 patients: A systematic review and meta-analysis.Asian Pac J Allergy Immunol. 2020 Sep;38(3):162-169. doi: 10.12932/AP-210520-0853. Asian Pac J Allergy Immunol. 2020. PMID: 32563232
Cited by
-
Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis.medRxiv [Preprint]. 2021 Oct 9:2021.10.09.21264771. doi: 10.1101/2021.10.09.21264771. medRxiv. 2021. Update in: Chem Senses. 2022 Jan 1;47:bjac001. doi: 10.1093/chemse/bjac001. PMID: 34671775 Free PMC article. Updated. Preprint.
-
Physiological plausibility of lower viral load in patients with COVID-19 and olfactory/gustatory dysfunction.Clin Otolaryngol. 2022 Mar;47(2):397-398. doi: 10.1111/coa.13892. Epub 2021 Nov 29. Clin Otolaryngol. 2022. PMID: 34773392 Free PMC article. No abstract available.
-
Ct, IL-18 polymorphism, and laboratory biomarkers for predicting chemosensory dysfunctions and mortality in COVID-19.Future Sci OA. 2023 Mar 9;9(2):FSO838. doi: 10.2144/fsoa-2022-0082. eCollection 2023 Feb. Future Sci OA. 2023. PMID: 36999046 Free PMC article.
-
Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis.Chem Senses. 2023 Jan 1;48:bjad043. doi: 10.1093/chemse/bjad043. Chem Senses. 2023. PMID: 38100383 Free PMC article.
-
SARS-Cov-2 Cycle Threshold Value and Olfactory Dysfunction in COVID-19 Patients.Iran J Otorhinolaryngol. 2023 Sep;35(130):263-273. doi: 10.22038/IJORL.2023.71462.3429. Iran J Otorhinolaryngol. 2023. PMID: 38090619 Free PMC article.
References
-
- Hopkins C, Surda P, Kumar N. Presentation of new onset anosmia during the COVID‐19 pandemic. Rhinology J. 2020;58(3):295‐298. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous